Scott Macleod, DO
General Practice · Las Vegas, NVNPI 1841359700
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.1% of the total across 341 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 32 manufacturers reported payments, led by AbbVie at 28.9% of the total. Among general practice clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 341 payments — averaging $26.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Johnson & Johnson$999
- LEO Pharma Inc.$664
- Galderma Laboratories, L.p.$579
- Dermavant Sciences, Inc.$470
- Sanofi$463
- plus $3K from 26 others
What the payments were for
- Food & beverage$8,55896%
- Education$3464%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 92 | $2,575 |
| Johnson & Johnson | 41 | $999 |
| LEO Pharma Inc. | 27 | $664 |
| Galderma Laboratories, L.p. | 16 | $579 |
| Dermavant Sciences, Inc. | 16 | $470 |
| Sanofi | 12 | $463 |
| Sun Pharmaceutical Industries Inc. | 17 | $336 |
| Lilly USA, LLC | 13 | $328 |
| Amgen | 10 | $281 |
| Novartis | 16 | $259 |
| E.r. Squibb & Sons, L.L.C. | 6 | $186 |
| Bristol Myers Squibb | 10 | $165 |
| Boehringer Ingelheim | 2 | $150 |
| Pfizer | 7 | $144 |
| Regeneron Healthcare Solutions, Inc. | 6 | $144 |
| UCB, Inc. | 5 | $140 |
| Incyte Corporation | 7 | $121 |
| Janssen Scientific Affairs, LLC | 1 | $115 |
| Organon | 6 | $96 |
| VYNE Pharmaceuticals Inc. | 5 | $94 |
| Arcutis Biotherapeutics, Inc. | 5 | $90 |
| Regeneron | 3 | $87 |
| Almirall LLC | 2 | $66 |
| Hill Dermaceuticals, Inc. | 1 | $62 |
| Dermira, Inc. | 2 | $48 |
| Strata Skin Sciences, Inc. | 3 | $48 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $46 |
| Mayne Pharma Commercial LLC | 2 | $43 |
| Sandoz | 2 | $39 |
| Kyowa Kirin, Inc. | 1 | $27 |
| Krystal Biotech Inc | 1 | $25 |
| Biofrontera Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,904 in reported general payments places this provider in the 95th percentile of 910 general practice providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 30 | $1,579 |
| Imiquimod | 31 | $873 |
| Tacrolimus | 15 | $839 |
| Doxycycline Hyclate | 26 | $631 |
| Fluocinonide | 14 | $442 |
| Ketoconazole | 33 | $416 |
| Mupirocin | 35 | $247 |
Paid to pharmacies, not to this prescriber.
Other general practice in Las Vegas
- Johnathan WhiteLas Vegas$1.5M
- Michael WebbersonLas Vegas$138K
- Yeong KimLas Vegas$82K
- Rewadee MeevasinLas Vegas$45K
- Joseph WillardsenLas Vegas$41K
- Arthur TomaroLas Vegas$37K
- Ali ShahrestaniLas Vegas$26K
- Shamshudin KheraniLas Vegas$22K
- Jong KimLas Vegas$19K
- Joseph BrownLas Vegas$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.